XOMA Royalty Corporation

8-K

Acquires Pulmokine for $20 Million Adding the Royalty and Milestone Interest in Seralutinib, a Phase 3 Asset, to Its Portfolio

12/02/24

10-Q

ended 09/30/24 Q3

11/07/24

8-K

Reports Third Quarter 2024 Financial Results and Highlights Recent Activities

11/07/24

8-K

Significantly Expands Its Royalty and Milestone Portfolio With the Addition of Over 60 Early-Stage Programs From Twist Bioscience

10/22/24

8-K

Zevra’s MIPLYFFA™ (Arimoclomol) Receives Approval From U.S. Food and Drug Administration for Use in Patients With Niemann-Pick Disease Type C

09/23/24

10-Q

ended 12/34/56 ##

08/13/24

8-K

####### ###### ####### #### ######### ####### ### ########## ###### ##########

08/13/24

8-K

######### ## ######## ## ############# ## ####### ## ###### ## ###### ##### ######### ########## ## ########

07/09/24

EFFECT

###### ## #############

06/17/24

EFFECT

###### ## #############

06/17/24

8-K/A

######### ### ##### ######### ######## ######### ###########

06/13/24

CORRESP

############## #### ### ###

06/13/24

CORRESP

############## #### ### ###

06/13/24

8-K

##### ######

05/30/24

8-K

########### #### #######

05/16/24

CORRESP

############## #### ### ###

05/10/24

10-Q

ended 12/34/56 ##

05/09/24

8-K

####### ##### ####### #### ######### ####### ### ########## ###### ##########

05/09/24

UPLOAD

###### #### ### ###

05/02/24

8-K

#### ######## ######### ## ##### ################# ###### ## ### ####### ### ######### ######### ######### ######## ############ ########## ####### ### ##

04/30/24

Search in Documents

Key Exhibits

External Links

Latest Filings – Non-Ownership Filter

Latest Filings – Ownership Filter

XOMA Royalty Corporation Watch

Search in Documents

Key Exhibits

External Links

Latest Filings – Non-Ownership Filter

Latest Filings – Ownership Filter

XOMA Royalty Corporation